Jerome Sarris

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. doi request reprint Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
    Jerome Sarris
    Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
    J Clin Psychopharmacol 33:643-8. 2013
  2. doi request reprint Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence
    Jerome Sarris
    Department of Psychiatry and The Melbourne Clinic, Faculty of Medicine, University of Melbourne, 2 Salisbury Street, Richmond, VIC 3121, Australia
    CNS Drugs 27:301-19. 2013
  3. doi request reprint St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT
    J Sarris
    Department of Psychiatry, The University of Melbourne, Melbourne, Australia
    Pharmacopsychiatry 45:275-8. 2012
  4. doi request reprint St. John's wort for the treatment of psychiatric disorders
    Jerome Sarris
    Department of Psychiatry, The Melbourne Clinic, The University of Melbourne, 2 Salisbury Street, Richmond, Victoria 3121, Australia
    Psychiatr Clin North Am 36:65-72. 2013
  5. doi request reprint Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, University of Melbourne, 2 Salisbury Street, Richmond, Vic, 3121, Australia
    CNS Drugs 27:207-19. 2013
  6. doi request reprint Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study
    J Sarris
    The University of Melbourne, Department of Psychiatry, Richmond, Melbourne, Victoria, Australia
    Traffic Inj Prev 14:13-7. 2013
  7. doi request reprint Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence
    Jerome Sarris
    The University of Melbourne, Department of Psychiatry, Australia
    Eur Neuropsychopharmacol 21:841-60. 2011
  8. doi request reprint 'Omic' genetic technologies for herbal medicines in psychiatry
    Jerome Sarris
    Professorial Unit, The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Australia
    Phytother Res 26:522-7. 2012
  9. doi request reprint The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study
    J Sarris
    The University of Melbourne, Department of Psychiatry, 2 Salisbury St, Richmond, Melbourne, Australia
    Hum Psychopharmacol 27:262-9. 2012
  10. ncbi request reprint Current challenges in appraising complementary medicine evidence
    Jerome Sarris
    Department of Psychiatry, University of Melbourne, Melbourne, Australia
    Med J Aust 196:310-1. 2012

Detail Information

Publications28

  1. doi request reprint Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
    Jerome Sarris
    Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
    J Clin Psychopharmacol 33:643-8. 2013
    ..Standardized kava may be a moderately effective short-term option for the treatment of GAD. Furthermore, specific GABA transporter polymorphisms appear to potentially modify anxiolytic response to kava. ..
  2. doi request reprint Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence
    Jerome Sarris
    Department of Psychiatry and The Melbourne Clinic, Faculty of Medicine, University of Melbourne, 2 Salisbury Street, Richmond, VIC 3121, Australia
    CNS Drugs 27:301-19. 2013
    ..and cannabidiol-enriched (low tetrahydrocannabinol (Δ(9)-THC)) Cannabis spp...
  3. doi request reprint St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT
    J Sarris
    Department of Psychiatry, The University of Melbourne, Melbourne, Australia
    Pharmacopsychiatry 45:275-8. 2012
    ..While the continuation data revealed an equivocal outcome between treatments at week 26, both SJW and sertraline were still therapeutically effective, with a pronounced "placebo-effect" impeding a significant result at week 26...
  4. doi request reprint St. John's wort for the treatment of psychiatric disorders
    Jerome Sarris
    Department of Psychiatry, The Melbourne Clinic, The University of Melbourne, 2 Salisbury Street, Richmond, Victoria 3121, Australia
    Psychiatr Clin North Am 36:65-72. 2013
    ..Mechanisms of action, including emerging pharmacogenetic data, safety, and clinical considerations are also detailed...
  5. doi request reprint Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, University of Melbourne, 2 Salisbury Street, Richmond, Vic, 3121, Australia
    CNS Drugs 27:207-19. 2013
    ..Future research should focus on conducting human clinical trials on the plants reviewed with promising anxiolytic activity...
  6. doi request reprint Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study
    J Sarris
    The University of Melbourne, Department of Psychiatry, Richmond, Melbourne, Victoria, Australia
    Traffic Inj Prev 14:13-7. 2013
    ..To date no controlled study has tested a medicinal dose of kava versus placebo and a standard sedative drug on driving ability and driving safety...
  7. doi request reprint Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence
    Jerome Sarris
    The University of Melbourne, Department of Psychiatry, Australia
    Eur Neuropsychopharmacol 21:841-60. 2011
    ..Several herbal medicines with in vitro and in vivo evidence are currently unexplored in human studies, and along with use of emerging genetic technologies "herbomics", are areas of potential future research...
  8. doi request reprint 'Omic' genetic technologies for herbal medicines in psychiatry
    Jerome Sarris
    Professorial Unit, The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Australia
    Phytother Res 26:522-7. 2012
    ..This paper focuses on the emerging field of herbomics, and is to our knowledge the first publication to explore this in the area of psychiatry...
  9. doi request reprint The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study
    J Sarris
    The University of Melbourne, Department of Psychiatry, 2 Salisbury St, Richmond, Melbourne, Australia
    Hum Psychopharmacol 27:262-9. 2012
    ....
  10. ncbi request reprint Current challenges in appraising complementary medicine evidence
    Jerome Sarris
    Department of Psychiatry, University of Melbourne, Melbourne, Australia
    Med J Aust 196:310-1. 2012
    ..In addition, providing intellectual property protection to CAM companies may encourage greater investment in research; however, more accountability of study results is critical...
  11. doi request reprint Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review
    Jerome Sarris
    The University of Melbourne, Faculty of Medicine, Department of Psychiatry, Richmond, Victoria, Australia
    J Affect Disord 138:213-21. 2012
    ....
  12. ncbi request reprint Clinical depression: an evidence-based integrative complementary medicine treatment model
    Jerome Sarris
    The University of Melbourne, Faculty of Medicine, Department of Psychiatry, Australia
    Altern Ther Health Med 17:26-37. 2011
    ..In practice, clinicians often use a variety of interventions; however, this approach may not be systematic, and many interventions used may not be based on strong evidence...
  13. doi request reprint Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, The University of Melbourne, Richmond, Victoria, Australia
    J Clin Psychiatry 73:81-6. 2012
    ..Thus, we present the significant findings from meta-analyses of omega-3 in the treatment of bipolar depression and bipolar mania...
  14. doi request reprint Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, The University of Melbourne, The Melbourne Clinic, Melbourne, Victoria, Australia
    J Altern Complement Med 17:881-90. 2011
    ..To date, no review has focused specifically on nonconventional treatments of BD...
  15. doi request reprint Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence
    Jerome Sarris
    The University of Melbourne, Department of Psychiatry, Australia
    Complement Ther Med 19:216-27. 2011
    ..In such vulnerable populations high quality evidence is required to support such claims...
  16. doi request reprint Kava: a comprehensive review of efficacy, safety, and psychopharmacology
    Jerome Sarris
    Department of Psychiatry, The Melbourne Clinic, The University of Melbourne, Victoria, Australia
    Aust N Z J Psychiatry 45:27-35. 2011
    ..Kava is available over the counter in jurisdictions such as the USA, Australia and New Zealand. Due to this, a review of efficacy, safety and clinical recommendations is advised...
  17. doi request reprint A systematic review of insomnia and complementary medicine
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
    Sleep Med Rev 15:99-106. 2011
    ..RCTs evaluating other untested CAM therapies such as massage, homoeopathy, or osteopathy are encouraged, as is the exploration of using CAM therapies adjuvantly with conventional therapies...
  18. doi request reprint Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, University of Melbourne, The Melbourne Clinic2 Salisbury Street, Richmond, Victoria 3121, Australia
    Bipolar Disord 13:454-65. 2011
    ..A subsequent aim of this report was to discuss posited underlying mechanisms of action...
  19. doi request reprint Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Jerome Sarris
    Department of Psychiatry, Faculty of Medicine, The University of Melbourne, Melbourne, Australia
    Planta Med 77:107-10. 2011
    ..The results of the study may be of benefit to sufferers of anxiety and the future economy of the Pacific islands, potentially providing an important step in the way forward with kava...
  20. doi request reprint Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence
    David A Camfield
    National Institute of Complementary Medicine Collaborative Centre for Neurocognition, Brain Sciences Institute, Swinburne University of Technology, Melbourne, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 35:887-95. 2011
    ..It is recommended that future clinical trials of nutraceutical treatments for OCD utilize randomized placebo-controlled study designs and considerably larger sample sizes in order to properly test for efficacy...
  21. doi request reprint Effects of multivitamin, mineral and herbal supplement on cognition in younger adults and the contribution of B group vitamins
    Andrew Pipingas
    Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia
    Hum Psychopharmacol 29:73-82. 2014
    ..This randomised, double-blind, placebo-controlled study investigated the cognitive effects of 16-week multivitamin supplementation in adults aged 20-49 years...
  22. pmc Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited
    Rolf Teschke
    Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Teaching Hospital of the Goethe University of Frankfurt Main, Hanau, Germany
    Br J Clin Pharmacol 73:170-4. 2012
    ..Rigorous testing of kava raw material is urgently advised, in addition to Pan-Pacific kava manufacturing quality standards...
  23. pmc Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial
    Jerome Sarris
    Department of Psychiatry, The University of Melbourne, Melbourne, Australia
    Nutr J 11:110. 2012
    ..While many randomised controlled trials have been conducted on multivitamins, to our knowledge no qualitative research exploring the subjective experience of taking a multivitamin during a clinical trial has been reported...
  24. doi request reprint The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials
    Matthew P Pase
    Centre for Human Psychopharmacology, Faculty of Life and Social Sciences, Swinburne University of Technology, Hawthorn, Australia
    J Altern Complement Med 18:647-52. 2012
    ..The current systematic review aimed to examine the scientific evidence as to whether Bacopa can enhance cognitive performance in humans...
  25. doi request reprint Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials
    Matthew P Pase
    NICM Centre for Study of Natural Medicines and Neurocognition, Melbourne, Australia
    Br J Nutr 106:974-80. 2011
    ..Reduction in arterial stiffness by n-3 may account for some of its purported cardioprotective effects...
  26. doi request reprint Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
    Chee Ng
    Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
    Hum Psychopharmacol 28:516-22. 2013
    ....
  27. ncbi request reprint Herbal medicines in the treatment of psychiatric disorders: a systematic review
    Jerome Sarris
    School of Medicine, Department of Psychiatry, University of Queensland, Brisbane, Australia
    Phytother Res 21:703-16. 2007
    ..Particular attention is given to clinical and safety issues with St John's wort and kava...
  28. doi request reprint The effects of dietary and nutrient interventions on arterial stiffness: a systematic review
    Matthew P Pase
    National Institute of Complementary Medicine Centre for Study of Natural Medicines and Neurocognition, Melbourne, Australia
    Am J Clin Nutr 93:446-54. 2011
    ..Although dietary and nutrient interventions have been extensively studied as a means of improving arterial stiffness, to our knowledge no systematic analysis of the data has been conducted...